Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association
Home
>
News
>
Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association
Print
Oligomerix
>
News
>
Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association
Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association
Post navigation
Previous Post
Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
Next Post
Oligomerix Receives $3.19 Million NIH Commercialization Readiness Pilot Grant for Alzheimer’s Disease Therapy
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
